Apollo Endosurgery, Inc. (APEN) News

Apollo Endosurgery, Inc. (APEN): $3.65

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter APEN News Items

APEN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest APEN News From Around the Web

Below are the latest news stories about Apollo Endosurgery Inc that investors may wish to consider to help them evaluate APEN as an investment opportunity.

Apollo Endosurgery up 17% after CFO adds shares

Apollo Endosurgery <> jumps after CFO Jeffrey G

Seeking Alpha | March 2, 2022

Apollo Endosurgery to Participate in the Cowen Healthcare Conference

AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8, 2022 as part of the Cowen Healthcare Conference, taking place virtually.

Yahoo | March 2, 2022

Investing in Apollo Endosurgery (NASDAQ:APEN) three years ago would have delivered you a 58% gain

Apollo Endosurgery, Inc. ( NASDAQ:APEN ) shareholders might understandably be very concerned that the share price has...

Yahoo | February 25, 2022

Apollo Endosurgery, Inc. 2021 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 23, 2022

Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q4 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 22, 2022

Apollo Endosurgery GAAP EPS of -$0.27 misses by $0.09, revenue of $16.2M in-line

Apollo Endosurgery press release (APEN): Q4 GAAP EPS of -$0.27 misses by $0.09.Revenue of $16.2M (+26.0% Y/Y) in-line.

Seeking Alpha | February 22, 2022

Apollo Endosurgery, Inc. (APEN) Reports Q4 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -35% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 22, 2022

Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021

* Increased adoption across all product lines in both U. and international * Grew fourth quarter 2021 revenue 26%AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc.

Yahoo | February 22, 2022

SARTORIUS (SARTF) Q4 Earnings and Revenues Surpass Estimates

SARTORIUS (SARTF) delivered earnings and revenue surprises of 1.24% and 1.82%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 17, 2022

Earnings Preview: Apollo Endosurgery, Inc. (APEN) Q4 Earnings Expected to Decline

Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 15, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4897 seconds.